Neuromodulation News and Research

RSS

Key protein regulates slow oxytocin release in the brain

The brain does not only communicate through fast electrical impulses; it also relies on slower, more diffuse chemical signals that modulate our emotional and social states over time.

19 Feb 2026

Review links betel nut addiction to cancer, heart disease, and metabolic risks

This review examines the epidemiology, health risks, neurobiological mechanisms, and emerging treatments related to betel nut addiction worldwide. It highlights strong links with oral cancer, cardiometabolic disease, and addiction pathways while noting limited established therapies and the need for coordinated public health strategies.

11 Feb 2026

Electroacupuncture relieves pain-induced anxiety through prefrontal neural circuits

Neuropathic pain, caused by injury or disease of the somatosensory nervous system, is a major clinical challenge and often evolves into a chronic condition.

7 Feb 2026

Brain network discovery opens new path for Parkinson’s treatment

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, movement difficulties, sleep disturbances and cognitive impairments.

4 Feb 2026

Research reveals dual impact of brain stimulation on people with depression and anxiety

Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and comorbid anxiety reveals a dual impact of this noninvasive form of brain stimulation.

29 Jan 2026

Ultra-thin nanotechnology enables safe wireless stimulation for retinal degeneration

An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering at Koç University has developed a next-generation, safe, and wireless stimulation technology for retinal degenerative diseases that cause vision loss.

23 Jan 2026

Integrated neural probes reveal dopaminergic control of sleep-wake transitions

Understanding the dynamic neural mechanisms of sleep-wake cycles is a major challenge in sleep science and neuroengineering.

6 Jan 2026

Understanding sevoflurane-induced neurogenesis inhibition and cognitive dysfunction in children

Every year, millions of infants and children undergo surgery under general anesthesia in the world. Sevoflurane is a commonly used pediatric anesthetic. Its exposure during brain development has been shown to inhibit neurogenesis and cause cognitive dysfunction in animal models.

5 Jan 2026

Unlocking sleep-wake secrets with dual brain signal analysis

Understanding the dynamic neural mechanisms of sleep-wake cycles is a major challenge in sleep science and neuroengineering.

22 Dec 2025

Short-term nitrous oxide treatment could benefit patients with major depressive disorder

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the University of Birmingham has found.

1 Dec 2025

Ultrasound technique modifies human reward learning for the first time

The nucleus accumbens is a tiny element of the human brain triggered when we experience something enjoyable, and used to help us learn behaviours that lead to rewards.

27 Nov 2025

Researchers launch phase 2 trial to test swallowing therapy for people with early Parkinson's

Swallowing difficulties, or dysphagia, affect up to 80% of people with Parkinson's disease and can lead to serious complications, including malnutrition, aspiration and reduced quality of life.

24 Nov 2025

Personalized brain stimulation approach shows promise for patients with drug-resistant epilepsy

Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy.

20 Nov 2025

Toward precision diagnosis and treatment of radiation-induced brain injury

Radiation-induced brain injury (RIBI) is a serious and often delayed complication of cranial radiotherapy, which remains a cornerstone in the treatment of brain tumors such as gliomas, metastases, and lymphomas.

18 Nov 2025

Brain recordings reveal short-lived effects of tirzepatide on food cravings

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain's "reward center" thought to be involved in food noise – but only temporarily.

17 Nov 2025

Emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder

In a peer-reviewed article published today in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD).

28 Oct 2025

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies.

28 Oct 2025

BD² expands global effort to examine the key mechanisms of bipolar disorder

Today, BD², or Breakthrough Discoveries for thriving with Bipolar Disorder, announced its third round of Discovery Research grants, totaling nearly $18 million – expanding a comprehensive global effort to examine the key mechanisms of bipolar disorder.

28 Oct 2025

Excess mortality associated with chronic pain can be avoided through spinal cord stimulation

Treating chronic neuropathic pain with spinal cord stimulation may help prevent excess mortality associated with chronic pain, a new study from the University of Eastern Finland and Kuopio University Hospital shows.

27 Oct 2025

New study offers hope for patients with treatment-resistant focal epilepsy

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies.

21 Oct 2025

Neuromodulation News and Research

Key protein regulates slow oxytocin release in the brain

Review links betel nut addiction to cancer, heart disease, and metabolic risks

Electroacupuncture relieves pain-induced anxiety through prefrontal neural circuits

Brain network discovery opens new path for Parkinson’s treatment

Research reveals dual impact of brain stimulation on people with depression and anxiety

Ultra-thin nanotechnology enables safe wireless stimulation for retinal degeneration

Integrated neural probes reveal dopaminergic control of sleep-wake transitions

Understanding sevoflurane-induced neurogenesis inhibition and cognitive dysfunction in children

Unlocking sleep-wake secrets with dual brain signal analysis

Short-term nitrous oxide treatment could benefit patients with major depressive disorder

Ultrasound technique modifies human reward learning for the first time

Researchers launch phase 2 trial to test swallowing therapy for people with early Parkinson's

Personalized brain stimulation approach shows promise for patients with drug-resistant epilepsy

Toward precision diagnosis and treatment of radiation-induced brain injury

Brain recordings reveal short-lived effects of tirzepatide on food cravings

Emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

BD² expands global effort to examine the key mechanisms of bipolar disorder

Excess mortality associated with chronic pain can be avoided through spinal cord stimulation

New study offers hope for patients with treatment-resistant focal epilepsy

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News